Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Market Dynamics 6.1 Growth Driver 6.1.1 Rising Cases of Diabetes 6.1.2 Rising Cases of Obesity 6.1.3 Rapid Urbanization 6.1.4 Increasing Healthcare Expenditure 6.1.5 Increasing Aging Population 6.2 Challenges 6.2.1 Short Half-Life of Glucagon-like Peptide 1 (GLP-1) Receptor Agonists 6.2.2 Unknown Severe Side Effects 6.3 Market Trends 6.3.1 Potential Clinical Application of GLP-1 Receptor Agonists For the Treatment of NASH 6.3.2 Surge in Research & Development in Pharmaceutical Sector 6.3.3 New Product Launches 6.3.4 Expanding Reimbursement Landscape 7
These are reference figures, not approved human dosing
Unless you've been living under a rock, you've likely heard of Ozempic (semaglutide) by now
Its also a fantastic glucose disposal agent
US$ 20.35
US$ 27.38
US$ 26.09
US$ 24.20
